Tag: Eye disease
DAZZLE clinical trial : Kodiak Sciences doses first patients with KSI-301 in phase 3 wet AMD trial
Kodiak Sciences said that it has treated the first patients in the phase 2 DAZZLE clinical trial of KSI-301, its investigational intravitreal anti-VEGF antibody biopolymer ... Read More
Dompé farmaceutici bags Oxervate FDA approval for neurotrophic keratitis
Oxervate FDA approval : Italian pharma company Dompé farmaceutici has bagged an approval for Oxervate (cenegermin) eye drops from the US Food and Drug Administration ... Read More